Education
About Us
Working with TipRanks
Follow Us
ALK-abello A/S Class B (AKBLF)
OTHER OTC:AKBLF
Comparison Results
Inovio Pharmaceuticals
$2.37
$178.63M
-0.92
33.15%
2 Buy
1 Hold
0 Sell
Moderate Buy
Emergent Biosolutions
$12.30
$641.27M
9.51
52.61%
1 Buy
0 Hold
0 Sell
Moderate Buy
Bristol-Myers Squibb
$53.33
$109.01B
18.08
-0.56%
8 Buy
11 Hold
1 Sell
Moderate Buy
Performance Comparison
AKBLF
ALK-abello
35.20
13.52
62.36%
DVAX
Dynavax
10.87
-1.89
-14.81%
INO
Inovio Pharmaceuticals
2.37
0.53
28.80%
ACRS
Aclaris Therapeutics
3.08
0.31
11.19%
EBS
Emergent Biosolutions
12.30
4.24
52.61%
NVS
Novartis
135.27
41.35
44.03%
BMY
Bristol-Myers Squibb
53.33
-0.30
-0.56%